Scholar Rock Holding Corp | - | 4.51% | - | - | 4,203 |
Xenon Pharmaceuticals Inc | - | 4.49% | - | - | 4,533 |
326030 | 4.43% | 95,600 | -2.75% | 2,156 | |
Neurocrine Biosciences Inc | - | 4.40% | - | - | 1,144 |
Biogen Inc | - | 4.27% | - | - | 1,079 |
Denali Therapeutics Inc | - | 4.27% | - | - | 9,755 |
ACADIA Pharmaceuticals Inc | - | 4.07% | - | - | 6,524 |
Supernus Pharmaceuticals Inc | - | 4.06% | - | - | 4,259 |
PTC Therapeutics Inc | - | 4.04% | - | - | 2,760 |
argenx SE ADR | - | 3.97% | - | - | 245 |
iShares Trust - iShares Neuroscience and Healthcare ETF is an exchange traded fund launched by BlackRock, Inc. It is managed by BlackRock Fund Advisors. The fund invests in public equity markets of global region. It invests in stocks of companies operating across neurology biopharmaceuticals or neurological devices sectors. The fund invests in growth and value stocks of companies across diversified market capitalization. It seeks to track the performance of the NYSE FactSet Global Neuro Biopharma and MedTech Index, by using representative sampling technique. iShares Trust - iShares Neuroscience and Healthcare ETF was formed on August 24, 2022 and is domiciled in the United States.